Search research articles
Contact Us
Filters
Showing results (61-70 of 159) with videos related to
Page
of 16
Sort By:
Gynecologic Oncology
|
November 18, 2025
Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?
Michael D Toboni, Elizabeth T Evans, Carly Bess Scalise, et al.
Journal of the Anus, Rectum and Colon
|
August 1, 2024
Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study)
Kozo Kataoka, Takeshi Yamada, Kentaro Yamazaki, et al.
Gynecologic Oncology
|
January 23, 2024
Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies
Fernando Recio, Carly Bess Scalise, Paul Loar, et al.
Mayo Clinic Proceedings
|
November 6, 2019
Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform Cancer Therapy
George Vasmatzis, Minetta C Liu, Sowjanya Reganti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2023
Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up
Sia V Lindskrog, Karin Birkenkamp-Demtröder, Iver Nordentoft, et al.
Annals of Surgical Oncology
|
July 23, 2025
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study
Ellery H Reason, Michael D Aiduk, Amanda L Nash, et al.
Cancers
|
July 24, 2021
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice
Lincoln D Nadauld, Charles H McDonnell, Tomasz M Beer, et al.
JCO Precision Oncology
|
July 19, 2023
Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies
Albert Jang, Sree M Lanka, Ellen B Jaeger, et al.
The Oncologist
|
December 13, 2019
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma
Sakti Chakrabarti, Tyler J Zemla, Daniel H Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2025
Circulating Tumor DNA Longitudinal Analysis During Total Neoadjuvant Therapy and Non-operative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial
Takashi Akiyoshi, Eiji Shinozaki, Yusuke Maeda, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 159) with videos related to
Sort By:
Page
of 16
Gynecologic Oncology
|
November 18, 2025
Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?
Michael D Toboni, Elizabeth T Evans, Carly Bess Scalise, et al.
Journal of the Anus, Rectum and Colon
|
August 1, 2024
Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study)
Kozo Kataoka, Takeshi Yamada, Kentaro Yamazaki, et al.
Gynecologic Oncology
|
January 23, 2024
Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies
Fernando Recio, Carly Bess Scalise, Paul Loar, et al.
Mayo Clinic Proceedings
|
November 6, 2019
Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform Cancer Therapy
George Vasmatzis, Minetta C Liu, Sowjanya Reganti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2023
Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up
Sia V Lindskrog, Karin Birkenkamp-Demtröder, Iver Nordentoft, et al.
Annals of Surgical Oncology
|
July 23, 2025
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study
Ellery H Reason, Michael D Aiduk, Amanda L Nash, et al.
Cancers
|
July 24, 2021
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice
Lincoln D Nadauld, Charles H McDonnell, Tomasz M Beer, et al.
JCO Precision Oncology
|
July 19, 2023
Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies
Albert Jang, Sree M Lanka, Ellen B Jaeger, et al.
The Oncologist
|
December 13, 2019
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma
Sakti Chakrabarti, Tyler J Zemla, Daniel H Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2025
Circulating Tumor DNA Longitudinal Analysis During Total Neoadjuvant Therapy and Non-operative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial
Takashi Akiyoshi, Eiji Shinozaki, Yusuke Maeda, et al.
Page
of 16